Vertex Pharmaceuticals Inc. buy Karakorum
Start price
08.01.22
/
80%
€196.52
Target price
14.01.27
€915.00
Performance (%)
89.75%
Price
22:26
€372.90
Summary
This prediction is currently active. The BUY prediction by Karakorum for Vertex Pharmaceuticals Inc. has seen massive gains of 89.75%. This prediction currently runs until 14.01.27. The prediction end date can be changed by Karakorum at any time. Karakorum has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.722% | -1.722% | 19.030% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% |
According to Karakorum what are the pros and cons of Vertex Pharmaceuticals Inc. for the foreseeable future?
Pros
Higher EBIT margin than peer group
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
ROE higher than 15% per year
Very capable Management
Very differentiated customer and product portfolio
Market Leader or Top 3
Very Future proof/growth oriented business model
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Very valuable balance sheet
Small challenges to pay loans and raise capital
Leading role in innovation
Strong uniques
Growths faster than the competition
Management is a major shareholder
Very small cyclical dependencies
Well known brand
Good culture
Sustainability is important
Medium risks for its business
Cons
Very low/no dividend yield expected
Comments by Karakorum for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Buy Vertex Pharmaceuticals Inc.
Kursziel gesetzt auf 975,0
Kursziel gesetzt auf 1.000,0
Kursziel geändert auf 975,0
Kursziel geändert auf 995,0
Kursziel geändert auf 905,0
Kursziel geändert auf 915,0